HomeAvailabilityGuidelinesOff Label UseDangersLinksBibliography
Intrauterine Fetal Death
36 articles identified (referenced to July 2008)
 
 
Review Articles
 
Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N.Engl.J.Med. 2001;344:38-47. [LINK]
Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second-trimester termination and intrauterine death. Best.Pract.Res.Clin.Obstet.Gynaecol. 2003;17:765-75. [LINK]
Sitruk-Ware R. Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception 2006;74:48-55. [LINK]
 
Gomez Ponce de Leon R. Wing D. Fiala C. Misoprostol for intrauterine fetal death. International Journal of Gynaecology & Obstetrics. 2007 Dec. 99 Suppl 2:S190-3.
 
 
Clinical Studies
 
Randomised Controlled Trials
 
Butt K, Delaney T, Hutchens D, Crane J, Young D. Randomized comparison of oral and vaginal misoprostol for midtrimester pregnancy termination for fetal demise and major congenital anomalies. American Journal of Obstetrics and Gynecology 2001;185:S205.

Chittacharoen A, Herabutya Y, Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet.Gynecol. 2003;101:70-3. [LINK]

Fadalla FA, Mirghani OA, Adam I. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester. Int.J.Gynaecol.Obstet. 2004;86:52-3. [LINK]
Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death in Mulago Hospital, Uganda. Afr.Health Sci. 2001;1:55-9. [LINK]
Nyende L, Towobola OA, Mabina MH. Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death. East Afr.Med.J. 2004;81:179-82. [LINK]
Elhassan EM. Abubaker MS. Adam I. Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise. International Journal of Gynaecology & Obstetrics. 2008 Jan. 100(1):82-3.
Vayrynen W. Heikinheimo O. Nuutila M. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica.2007 86(6):701-5. 
 
 
 
Observational Studies
 
Al Taani MI. Termination of second trimester, complicated gestation. East Mediterr.Health J. 2005;11:657-62. [LINK]
Bique C, Bugalho A, Bergstrom S. Labor induction by vaginal misoprostol in grand multiparous women. Acta Obstet.Gynecol.Scand. 1999;78:198-201. [LINK]
Bugalho A, Bique C, Machungo F, Faaundes A. Induction of labor with intravaginal misoprostol in intrauterine fetal death. Am.J.Obstet.Gynecol. 1994;171:538-41. [LINK]
Bugalho A, Bique C, Machungo F, Bergstrom S. Vaginal misoprostol as an alternative to oxytocin for induction of labor in women with late fetal death. Acta Obstet.Gynecol.Scand. 1995;74:194-8. [LINK]
Clark S, Blum J, Blanchard K, Galvao L, Fletcher H, Winikoff B. Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States. Int.J.Gynaecol.Obstet. 2002;76:65-74. [LINK]
Daskalakis G, Efthimiou T, Pilalis A, Papadopoulos D, Anastasakis E, Fotinos G et al. Prenatal diagnosis and management of fetal pharyngeal teratoma: a case report and review of the literature. J.Clin.Ultrasound 2007;35:159-63. [LINK]
de Boer MA, van Gemund N, Scherjon SA, Kanhai HHH. Low dose sulprostone for termination of second and third trimester pregnancies. European Journal of Obstetrics Gynecology and Reproductive Biology 2001;99:244-8. [LINK]
De Heus R, Graziosi GC, Christiaens GC, Bruinse HW, Mol BW. Medical management for termination of second and third trimester pregnancies: a comparison of strategies. Eur.J.Obstet.Gynecol.Reprod.Biol. 2004;116:16-21. [LINK]
Dodd J, O'Brien L, Coffey J. Misoprostol for second and third trimester termination of pregnancy: a review of practice at the Women's and Children's Hospital, Adelaide, Australia. Aust.N.Z.J.Obstet.Gynaecol. 2005;45:25-9. [LINK]
Fairley TE, Mackenzie M, Owen P, Mackenzie F. Management of late intrauterine death using a combination of mifepristone and misoprostol--experience of two regimens. Eur.J.Obstet.Gynecol.Reprod.Biol. 2005;118:28-31. [LINK]
Fawole AO, Adekunle AO, Sotiloye OS, Arowojolu AO, Otolorin EO. Experience with intravaginal misoprostol in the management of intra-uterine fetal death. Afr.J.Med.Med.Sci. 2004;33:105-8. [LINK]
Fisteag-Kiprono L, Foster K, McKenna D, Baptista M. Antenatal sonographic diagnosis of massive subchorionic hematoma: a case report. J.Reprod.Med. 2005;50:219-21. [LINK]
Hoffman MK,.Sciscione AC. Placenta accreta and intrauterine fetal death in a woman with prior endometrial ablation: a case report. J.Reprod.Med. 2004;49:384-6. [LINK]
le Roux PA, Pahal GS, Hoffman L, Nooh R, El Refaey H, Rodeck CH. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost. Eur.J.Obstet.Gynecol.Reprod.Biol. 2001;95:52-4. [LINK]
Merrell DA,.Koch MA. Induction of labour with intravaginal misoprostol in the second and third trimesters of pregnancy. S.Afr.Med.J. 1995;85:1088-90. [LINK]
Ostrom K, Ben Arie A, Edwards C, Gregg A, Chiu JK, Kaplan AL. Uterine evacuation with misoprostol during radiotherapy for cervical cancer in pregnancy. Int.J.Gynecol.Cancer 2003;13:340-3. [LINK]
Pongsatha S,.Tongsong T. Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol. J.Obstet.Gynaecol.Res. 2004;30:217-20. [LINK]
Vayrynen W, Heikinheimo O, Nuutila M. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death. Acta Obstet.Gynecol.Scand. 2007;86:701-5. [LINK]
Verhulsdonk MT, Papatsonis DN, Heydanus R. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study]. Ned.Tijdschr.Geneeskd. 2007;151:815-20. [LINK]
Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG. 2002;109:443-7. [LINK]
 
Verhulsdonk MT. Papatsonis DN. Heydanus R. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study]. [Dutch] Nederlands Tijdschrift voor Geneeskunde. 2007 Apr.151(14):815-20,
 
Cost-effectiveness
 
No articles identified
 
 
Pharmacology
 
No articles identified
 
 
Basic Science
 
Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N.Engl.J.Med. 2001;344:38-47. [LINK]
Sitruk-Ware R. Mifepristone and misoprostol sequential regimen side effects, complications and safety. Contraception 2006;74:48-55. [LINK]
 
 
Politics/ Licensing/ Ethics
 
No articles identified
 
 
Editorials/ Letters/ Opinions
 
Kleinhaus K,.Teal S. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet.Gynecol. 2003;101:1353-4. [LINK]
 
 
Unspecified
 
Mariani NC, Leao EJ, Barreto EM, Kenj G, de Aquino MM, Tuffi VH. [Use of misoprostol for labor induction in stillbirth]. Rev.Paul Med. 1987;105:325-8. [LINK]